Kasaian M T, Casali P
Department of Pathology, New York University School of Medicine, New York 10016.
Autoimmunity. 1993;15(4):315-29. doi: 10.3109/08916939309115755.
The delineation of distinct subsets committed to the production of antibodies with different antigen-binding activities supports the view of a compartmentalization and specialization of function in the B cell repertoire and is consistent with the hypothesis of a developmentally layered immune system; as originally proposed by Herzenberg and Herzenberg. On the basis of the data by Solvason and Kearney in the human fetus and our data in the adult, and in agreement with the findings of Herzenberg et al. and Hardy et al. in the mouse, we propose that the human B cell repertoire includes at least three distinct B cell subsets: B-1a cells, which develop from progenitors in the fetal splanchnic district, namely the omentum, and are maintained in adult life by virtue of their self-replenishing nature; B-1b cells, progenitors of which can be found in the splanchnic district and, perhaps, adult bone marrow; and, finally, B-2 cells, which arise in the fetal liver and are continuously replenished in adult life by progenitors in the bone marrow (Figure 5). The different B cells types are distinguished by their differential expression of surface CD5 and, perhaps, CD11b and CD14, their differential expression of CD5 mRNA, and the different classes and specificities of the Ig they produce (Figure 5). B-1 lymphocytes play a major role in autoimmunity and constitute the physiological equivalent of the neoplastic forms in various lymphoproliferative disorders, such as CLL and SLL, which are often associated with the production of monoclonal antibodies to self antigens. Human B-1a (CD5+ B) and B-1b (CD5- CD45RAlo B) cells are responsible for the production of natural (polyreactive and monoreactive) antibodies in the fetus, neonate, and adult, and can give rise to the autoantibody-producing cells characteristic of several autoimmune disease states. Our recent findings suggest that while in healthy subjects the majority of natural polyreactive antibodies is encoded in V genes in germline configuration, some polyreactive antibodies are encoded in somatically mutated V genes, in a fashion consistent with an antigen-driven process of selection of such mutations. The nature of the antigen(s) involved in these selection processes remains to be determined. Under possibly different circumstances, the application of an antigen-driven process of clonal selection to B-1a and/or B-1b cells, previously committed to natural antibody production, can result in the generation of monoreactive high affinity and possibly pathogenic autoantibodies (Figures 5A and 5B).(ABSTRACT TRUNCATED AT 400 WORDS)
明确区分出致力于产生具有不同抗原结合活性抗体的不同亚群,这支持了B细胞库中功能分区化和专业化的观点,并且与发育分层免疫系统的假说相一致;该假说最初由赫岑伯格和赫岑伯格提出。基于索尔瓦松和卡尼在人类胎儿中的数据以及我们在成年人中的数据,并与赫岑伯格等人和哈迪等人在小鼠中的研究结果一致,我们提出人类B细胞库至少包括三个不同的B细胞亚群:B-1a细胞,它们从胎儿内脏区(即大网膜)的祖细胞发育而来,并因其自我更新的特性在成年期得以维持;B-1b细胞,其祖细胞可在内脏区以及或许在成年骨髓中找到;最后是B-2细胞,它们在胎儿肝脏中产生,并在成年期由骨髓中的祖细胞持续补充(图5)。不同类型的B细胞通过其表面CD5以及或许CD11b和CD14的差异表达、CD5 mRNA的差异表达以及它们产生的Ig的不同类别和特异性来区分(图5)。B-1淋巴细胞在自身免疫中起主要作用,并且在各种淋巴增殖性疾病(如慢性淋巴细胞白血病和小淋巴细胞淋巴瘤)中构成肿瘤形式的生理对应物,这些疾病常与针对自身抗原的单克隆抗体的产生相关。人类B-1a(CD5+B)和B-1b(CD5 - CD45RAlo B)细胞在胎儿、新生儿和成年人中负责产生天然(多反应性和单反应性)抗体,并且可产生几种自身免疫疾病状态所特有的产生自身抗体的细胞。我们最近的研究结果表明,在健康受试者中,虽然大多数天然多反应性抗体由种系构型的V基因编码,但一些多反应性抗体由体细胞突变的V基因编码,其方式与这种突变的抗原驱动选择过程一致。参与这些选择过程的抗原的性质仍有待确定。在可能不同的情况下,将抗原驱动的克隆选择过程应用于先前致力于天然抗体产生的B-1a和/或B-1b细胞,可导致产生单反应性高亲和力且可能具有致病性的自身抗体(图5A和5B)。(摘要截断于400字)